Execs On The Move, October 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

New At The Helm

Company Changes

ALBRIGHT, Charles, PhD

To: Editas Medicine Inc., CSO (August)

From:Bristol-Myers Squibb Co., VP, Genetically Defined Diseases & Genomics

Phone:[phone]

BAERTSCHI, Gabriel

To: Grunenthal Group, Chairman & CEO (October)

From:AstraZeneca PLC, Pres., Japan

Phone:[phone]

BARTON, Jeremy, MD

To: eFFECTOR Therapeutics Inc., CMO (September)

From:Pfizer Inc., VP, Head, Oncology Early Dev. & Clinical Research

Phone:[phone]

BRADRICK, Brittany

To: Insulet Corp., VP, Strategy & Corp. Dev. (September)

From:Abbott Diabetes Care, Dir., Bus. Dev. & Alliance Mgmt.

Phone:[phone]

CASCIANO, Tony

To: AMAG Pharmaceuticals Inc., SVP, Sales & Mktg., Hematology & Oncology (September)

From:Sanofi, Head, Mktg., General Medicine

Phone:[phone]

COUTURIER, Christophe

To: OvaScience Inc., CFO (September)

From:Merck KGAA, SVP, General Mgr.

Phone:[phone]

EKLUND, Mike

To: DJO Global Inc., COO & CFO (September)

From:Dell/EMC, SVP, Value Creation & Integration Mgmt.

Phone:[phone]

FOSTER, Jonathan P.

To: Moleculin Biotech Inc., EVP, CFO (August)

From:InfuSystem Holdings Inc., EVP, CFO

Phone:[phone]

GARDNER, Humphrey A.R., MD

To: Karyopharm Therapeutics Inc., SVP, Clinical Dev. (September)

From:AstraZeneca PLC, Clinical VP, Translational Medicine

Phone:[phone]

HOFFMAN, Robert

To: Innovus Pharmaceuticals Inc., EVP, CFO (September)

From:AnaptysBio Inc., CFO

Phone:[phone]

HUANG, Jane, MD

To: BeiGene (Beijing) Co. Ltd., CMO, Hematology (September)

From:Acerta Pharma BV, VP, Head, Dev.

Phone:[phone]

ISACSON, Ole, MD

To: Pfizer Inc., SVP, CSO, Neuroscience Research Unit (September)

From:Harvard Medical School, Professor, Neurology

Phone:[phone]

LEMIEUX, Stephen L.

To: Cipher Pharmaceuticals Inc., CFO (September)

From:Nuvo Pharmaceuticals, VP, CFO

Phone:[phone]

MCDONALD, Damien

To: LivaNova PLC, COO (October)

From:Danaher Corp., Group Exec. & Corp. VP

Phone:[phone]

MILLAR, Anthony

To: Minnetronix Inc., VP, Operations (August)

From:Greatbatch Inc., Exec. Dir., Operations

Phone:[phone]

MONAHAN, Rob

To: Akorn Inc., SVP, Corp. Dev. (August)

From:Walgreens Boots Alliance Inc., VP, Mergers & Acquisitions

Phone:[phone]

MOODY, Philip K.

To: PaxVax Inc., CFO (August)

From:BTG PLC, CFO, North America

Phone:[phone]

MOORE, Melissa J., PhD

To: Moderna Therapeutics LLC, CSO (September)

From:Howard Hughes Medical Institute, Chair, Cancer Research & Investigator

Phone:[phone]

MOZAYENI, Cyrus D., MD

To: Oncorus Inc., Pres. & CBO (September)

From:bluebird bio Inc., VP, Global Head, Bus. Dev. & Alliance Mgmt.

Phone:[phone]

O’DOWD, Hugh

To: Neon Therapeutics, CEO (September)

From:Novartis AG, Country Pres. & General Mgr., UK & Ireland

Phone:[phone]

OLSEN, Russell

To: Derma Sciences Inc., Pres., Advanced Wound Care (August)

From:BioD LLC, Pres. & CEO

Phone:[phone]

PAOLINO, Sean

To: BioNano Genomics Inc., VP, Finance (September)

From:FP&A Consultant

Phone:[phone]

PASS, David, PharmD

To: Gelesis Inc., COO (September)

From:Boehringer Ingelheim GMBH, VP, Mktg., Diabetes

Phone:[phone]

PENG, Stanford, MD, PhD

To: Alpine Immune Sciences Inc., EVP, CMO (September)

From:Stemcentrx Inc., CMO, Head, Dev.

Phone:[phone]

PETERSON, Amy C., MD

To: BeiGene (Beijing) Co. Ltd., CMO, Immuno-oncology (August)

From:Medivation Inc., VP, Clinical Dev.

Phone:[phone]

SACKS, Natalie R., MD

To: Aduro Biotech Inc., CMO (September)

From:Advisor, Development Strategy

Phone:[phone]

SANDOVAL, Elisabeth A.

To: Alder BioPharmaceuticals Inc., Chief Commercial Officer (September)

From:Kythera Biopharmaceuticals Inc., Chief Commercial Officer

Phone:[phone]

SCHROFF, Matthias, PhD

To: Vaximm AG, CEO (September)

From:Mologen AG, CEO

Phone:[phone]

SENDER, Susan, RN

To: Amedisys Inc., SVP, Chief Clinical Officer (September)

From:Kindred at Home, SVP, Chief Clinical Officer

Phone:[phone]

SHAIR, Karoline, PhD

To: Forma Therapeutics Holdings LLC, VP, Legal & Chief IP Counsel (August)

From:Takeda Pharmaceuticals International Co. Ltd., VP, IP Region Head

Phone:[phone]

SHEGOG, Todd E.

To: Synlogic Inc., CFO (September)

From:Forum Pharmaceuticals Inc., SVP, CFO

Phone:[phone]

VIBOCH, Elena

To: Carmot Therapeutics Inc., Dir., Bus. Dev. & Operations (August)

From:FLX Bio Inc., Senior Mgr., Corp. Dev. & Strategy

Phone:[phone]

WEINTRAUB, Scott

To: Concert Pharmaceuticals Inc., VP, Commercial & Product Strategy (September)

From:Forum Pharmaceuticals Inc., VP, Product Strategy & Mktg.

Phone:[phone]

WHOLIHAN, Edward

To: Allena Pharmaceuticals Inc., CFO (September)

From:Medical Specialties Distributors, CFO

Phone:[phone]

WILKE, Susanne, PhD

To: Neurotrope Inc., CEO (September)

From:CrossBridge International, Pres. & CEO

Phone:[phone]

VANDERPUTTEN, Dale, PhD

To: Nutra Pharma Corp., CSO (August)

From:Omnia Biologics Inc., CEO & CSO

Phone:[phone]

ZADNO, Reza, PhD

To: Avedro Inc., CEO (September)

From:Visiogen Inc., Pres. & CEO

Phone:[phone]

Directors

ALEXANDER, Robert, PhD

To: Allena Pharmaceuticals Inc., Director (September)

Phone:[phone]

BANERJI, Shumeet, PhD

To: Berg Pharma Inc., Director (August)

Phone:[phone]

BARKER, David, PhD

To: BioNano Genomics Inc., Chairman (September)

Phone:[phone]

BLECH, Isaac

To: Diffusion Pharmaceuticals Inc., Director (August)

Phone:[phone]

BOSE, Arindam, PhD

To: Dyadic International Inc., Director (August)

Phone:[phone]

BRUGHERA, Marco, DVM

To: Fennec Pharmaceuticals Inc., Director (August)

Phone:[phone]

BRUHN, Suzanne, PhD

To: Pliant Therapeutics Inc., Director (August)

Phone:[phone]

DAVIDSON, Aaron

To: Nutrinia, Director (August)

Phone:[phone]

FISCHER, Seth H.Z.

To: Marinus Pharmaceuticals Inc., Director (September)

Phone:[phone]

GRANGER, Elder, MD

To: Berg Pharma Inc., Director (August)

Phone:[phone]

HEGE, Kristen M., MD

To: Mersana Therapeutics Inc., Director (September)

Phone:[phone]

JONES, Suzy

To: Calithera Biosciences Inc., Director (August)

Phone:[phone]

MANDEL, Victor

To: MYOS RENS Technology Inc., Director (September)

Phone:[phone]

NADAV, Eran, PhD

To: Nutrinia, Director (August)

Phone:[phone]

NESTLER, Eric, MD, PhD

To: Berg Pharma Inc., Director (August)

Phone:[phone]

WILLIAMS, Patrick F.

To: Miramar Labs Inc., Director (August)

Phone:[phone]

ZACCARDELLI, David, PharmD

To: Cempra Inc., Director (August)

Phone:[phone]

Advisors

COX, Bryan F., PhD

To: Mount Tam Biotechnologies, Scientific Advisor (September)

Phone:[phone]

CUMMINGS, Jeffrey, MD, ScD

To: Accera Inc., Scientific Advisor (September)

Phone:[phone]

FLAHERTY, Keith, MD

To: Aeglea BioTherapeutics Inc., Scientific Advisor (September)

Phone:[phone]

FRANKEL, Arthur, MD

To: Aeglea BioTherapeutics Inc., Scientific Advisor (September)

Phone:[phone]

KENNEY, W. Larry, PhD

To: Flex Pharma Inc., Scientific Advisor (August)

Phone:[phone]

KLOHS, Wayne, PhD

To: Aeglea BioTherapeutics Inc., Scientific Advisor (September)

Phone:[phone]

VANDER HEIDEN, Matthew, MD, PhD

To: Aeglea BioTherapeutics Inc., Scientific Advisor (September)

Phone:[phone]

VELLAS, Bruno, MD, PhD

To: Accera Inc., Scientific Advisor (September)

Phone:[phone]

VON HOFF, Daniel D., MD

To: Aeglea BioTherapeutics Inc., Scientific Advisor (September)

Phone:[phone]

Promotions

COHARD-RADICE, Marielle, MD

To: Daiichi Sankyo Inc.

New Title:EVP, Global Head, Dev. (September)

Previous Title:VP, Clinical Dev. Operations, Pharma Dev.

Phone:[phone]

PHILLIPS, Andrew, PhD

To: C4 Therapeutics Inc.

New Title:Pres. & CSO (September)

Previous Title:CSO

Phone:[phone]

ROBINSON, Warren

To: BioNano Genomics Inc.

New Title:VP, Global Sales & Mktg. (September)

Previous Title:VP, Commercial, North America

Phone:[phone]

STUHLMILLER, David F.E., MD

To: Air Methods Corp.

New Title:CMO (September)

Previous Title:Physician Advisor

Phone:[phone]

WARD, Scott R.

To: Cardiovascular Systems Inc.

New Title:Chairman & CEO (August)

Previous Title:Chairman, Interim Pres. & CEO

Phone:[phone]

Resignations

CONNORS, Kevin

From: Cutera Inc., Pres. & CEO (August)

Phone:[phone]

DE CLARA, Maximilian

From: CEL-SCI Corp., Chairman & Pres. (September)

Phone:[phone]